Ribbon Acquisition Corp - Unit | 10-Q: FY2025 Q2 EPS: USD 0.11

EPS: As of FY2025 Q2, the actual value is USD 0.11.

The company has not generated any operating revenues as of June 30, 2025, since it is a blank check company focused on identifying a target for a business combination.

For the three months ended June 30, 2025, the company reported a net income of $271,297, which included operating expenses of $242,894 and income earned on marketable securities held in the Trust Account of $514,191.
For the six months ended June 30, 2025, the company reported a net income of $507,153, with operating expenses of $428,295 and income earned on marketable securities held in the Trust Account of $935,448.

Net cash used in operating activities for the six months ended June 30, 2025, was - $418,288.
Net cash used in investing activities was - $50,000,000, primarily due to the purchase of marketable securities held in the Trust Account.
Net cash provided by financing activities was $50,710,916, which included proceeds from the sale of public units and private placements.

The company completed its Initial Public Offering (IPO) on January 16, 2025, raising gross proceeds of $50,000,000 through the sale of 5,000,000 units at $10.00 per unit.
Simultaneously, a private placement of 220,000 units was completed, generating additional proceeds of $2,200,000.

Core Business Focus: The company is focused on completing a business combination within 12 months from the IPO date, using the proceeds from the IPO and private placement to finance the acquisition and subsequent operations of the target business.
Non-Core Business: The company has entered into a Business Combination Agreement with DRC Medicine Inc., DRC Medicine Ltd., and DRC Merger Inc., which involves a series of transactions to merge and domesticate as a Delaware corporation.
The company has until January 16, 2026, to complete the business combination, failing which it will liquidate and return funds to shareholders.